(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.(b)(4).The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents from this lot.It should be noted that the supera instruction for use (ifu)) states: use this device prior to the use-by-date as specified on the device package label.The investigation determined the reported complaint was due to user error.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
|
It was reported that on (b)(6) 2017, a 5.0x80mm 6f 120cm supera peripheral self-expanding stent was successfully deployed in a popliteal artery with no adverse patient effects and no device difficulties.On (b)(6) 2017, it was discovered that the implanted stent had expired on (b)(6) 2017.There have been no adverse patient effects to date.No additional information was provided.
|